1-8 of 8
Lanlan Shen
Close
Sort by
Journal Articles

Limited Effect of TET2 Mutations on Promoter DNA Methylation in Chronic Myelomonocytic Leukemia

Jumpei Yamazaki, DVM, PhD, Rodolphe F Taby, MD, Aparna Vasanthakumar, PhD, Trisha Macrae, Kelly R Ostler, BA, Lanlan Shen, MD, PhD, Hagop M. Kantarjian, Marcos R Estecio, PhD, Jaroslav Jelinek, MD, PhD, Lucy Godley, MD, PhD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2011) 118 (21): 1365.
https://doi.org/10.1182/blood.V118.21.1365.1365
Published: 2011
Journal Articles

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse

Heike Kroeger, Jaroslav Jelinek, Marcos R. H. Estécio, Rong He, Kimie Kondo, Woonbok Chung, Li Zhang, Lanlan Shen, Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Jean-Pierre J. Issa
Journal: Blood
Blood (2008) 112 (4): 1366–1373.
https://doi.org/10.1182/blood-2007-11-126227
Published: 2008
Includes: Supplemental data
Journal Articles

Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia

Brief Report
Yasuhiro Oki, Jaroslav Jelinek, Lanlan Shen, Hagop M. Kantarjian, Jean-Pierre J. Issa
Journal: Blood
Blood (2008) 111 (4): 2382–2384.
https://doi.org/10.1182/blood-2007-07-103960
Published: 2008
Journal Articles

Aberrant DNA Methylation in CML Is Associated with Disease Progression and Resistance to Imatinib Mesylate.

Jaroslav Jelinek, MD, PhD, Vazganush Gharibyan, Yasuhiro Oki, MD, Woonbok Chung, PhD, Lanlan Shen, MD PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Jean-Pierre J. Issa, MD
Journal: Blood
Blood (2006) 108 (11): 2192.
https://doi.org/10.1182/blood.V108.11.2192.2192
Published: 2006
Journal Articles

Comprehensive Promoter Methylation Analysis of Genes on 5q31.1 in MDS and AML.

Yasuhiro Oki, MD, Jaroslav Jelinek, M.D, PhD, Lanlan Shen, M.D, PhD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2005) 106 (11): 3443.
https://doi.org/10.1182/blood.V106.11.3443.3443
Published: 2005
Journal Articles

CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is Reversed by Decitabine Therapy-Results of a Phase III Randomized Study.

Lanlan Shen, MD, PhD, Hagop Kantarjian, MD, Hussain Saba, MD, E. Lin, Don Berry, Saira Ahmed, Jaroslav Jelinek, MD, Jean-Pierre J. Issa, MD
Journal: Blood
Blood (2005) 106 (11): 790.
https://doi.org/10.1182/blood.V106.11.790.790
Published: 2005
Journal Articles

Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia

LanLan Shen, Minoru Toyota, Yutaka Kondo, Toshiro Obata, Sophia Daniel, Sherry Pierce, Kohzoh Imai, Hagop M. Kantarjian, Jean-Pierre J. Issa, Guillermo Garcia-Manero
Journal: Blood
Blood (2003) 101 (10): 4131–4136.
https://doi.org/10.1182/blood-2002-08-2466
Published: 2003
Journal Articles

Lack of p21 CIP1 DNA methylation in acute lymphocytic leukemia

LanLan Shen, Yutaka Kondo, Jean-Pierre Issa, Guillermo Garcia-Manero
Journal: Blood
Blood (2002) 100 (9): 3432–3433.
https://doi.org/10.1182/blood-2002-07-1990
Published: 2002